Mart P Janssen (Mart Janssen, M P Janssen)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Topics

Decision Making

Kidney Transplantation

Top Venues

Journal of clinical medicine

Transfusion medicine (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen
Extensive red blood cell matching considering patient alloimmunization risk. Vox sanguinis 119 (4) (2024)
Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen
Extensive red blood cell matching considering patient alloimmunization risk. Vox sanguinis (2024)
Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen
Extensive red blood cell matching considering patient alloimmunization risk. Vox sanguinis 119 (4) (2024)
Amber Meulenbeld, Jarkko Toivonen, Marieke Vinkenoog, Tinus Brits, Ronel Swanevelder, Dorien de Clippel, Veerle Compernolle, Surendra Karki, Marijke Welvaert, Katja van den Hurk, Joost van Rosmalen, Emmanuel Lesaffre, Mart P Janssen, Mikko Arvas
Predicting haemoglobin deferral using machine learning models: Can we use the same prediction model across countries? Vox sanguinis 119 (7) (2024)
Amber Meulenbeld, Jarkko Toivonen, Marieke Vinkenoog, Tinus Brits, Ronel Swanevelder, Dorien de Clippel, Veerle Compernolle, Surendra Karki, Marijke Welvaert, Katja van den Hurk, Joost van Rosmalen, Emmanuel Lesaffre, Mart P Janssen, Mikko Arvas
Predicting haemoglobin deferral using machine learning models: Can we use the same prediction model across countries? Vox sanguinis (2024)
Judita Rudokaite, Itir Onal Ertugrul, Sharon Ong, Mart P Janssen, Elisabeth M J Huis In 't Veld
Predicting Vasovagal Reactions to Needles from Facial Action Units. Journal of clinical medicine 12 (4) (2023)
Judita Rudokaite, Itir Onal Ertugrul, Sharon Ong, Mart P Janssen, Elisabeth M J Huis In 't Veld
Predicting Vasovagal Reactions to Needles from Facial Action Units. Journal of clinical medicine 12 (4) (2023)
Marieke Vinkenoog, Jarkko Toivonen, Matthijs van Leeuwen, Mart P Janssen, Mikko Arvas
The added value of ferritin levels and genetic markers for the prediction of haemoglobin deferral. Vox sanguinis (2023)
Marieke Vinkenoog, Jarkko Toivonen, Tinus Brits, Dorien de Clippel, Veerle Compernolle, Surendra Karki, Marijke Welvaert, Amber Meulenbeld, Katja van den Hurk, Joost van Rosmalen, Emmanuel Lesaffre, Mikko Arvas, Mart P Janssen
An international comparison of haemoglobin deferral prediction models for blood banking. Vox sanguinis (2023)
Judita Rudokaite, Itir Onal Ertugrul, Sharon Ong, Mart P Janssen, Elisabeth M J Huis In 't Veld
Predicting Vasovagal Reactions to Needles from Facial Action Units. Journal of clinical medicine 12 (4) (2023)
Judita Rudokaite, Itir Onal Ertugrul, Sharon Ong, Mart P Janssen, Elisabeth M J Huis In 't Veld
Predicting Vasovagal Reactions to Needles from Facial Action Units. Journal of clinical medicine 12 (4) (2023)
Merel L Wemelsfelder, Dick den Hertog, Onno Wisman, Jarkko Ihalainen, Mart P Janssen
Determining optimal locations for blood distribution centers. Transfusion 62 (12) (2022)
Jessie S Luken, Sebastien P Ritsema, Merel M Van der Wal, C Ellen Van Der Schoot, Etiënne A J A Rouwette, Masja De Haas, Mart P Janssen
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach. Transfusion medicine (Oxford, England) 32 (5) (2022)
Marieke Vinkenoog, Rosa de Groot, Jeroen Lakerveld, Mart P Janssen, Katja van den Hurk
Individual and environmental determinants of serum ferritin levels: A structural equation model. Transfusion medicine (Oxford, England) 33 (2) (2022)
Shannon K S Kroes, Matthijs van Leeuwen, Rolf H H Groenwold, Mart P Janssen
Generating synthetic mixed discrete-continuous health records with mixed sum-product networks. Journal of the American Medical Informatics Association : JAMIA (2022)
Esa V Turkulainen, Merel L Wemelsfelder, Mart P Janssen, Mikko Arvas
A robust autonomous method for blood demand forecasting. Transfusion 62 (6) (2022)
Christie Vermeulen, Gijs den Besten, Annegeet G van den Bos, Mya Go, Eric Gouwerok, Richard Vlaar, Martin R Schipperus, Saskia E Spelmink, Mart P Janssen, Johan W Lagerberg, Dirk de Korte, Thomas R L Klei
Clinical and in vitro evaluation of red blood cells collected and stored in a non-DEHP plasticized bag system. Vox sanguinis 117 (10) (2022)
Mart P Janssen
Why the majority of on-site repeat donor deferrals are completely unwarranted…. Transfusion 62 (10) (2022)
Marieke Vinkenoog, Matthijs van Leeuwen, Mart P Janssen
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply. Vox sanguinis 117 (11) (2022)
Sara Moazzen, Maike G Sweegers, Mart P Janssen, Boris M Hogema, Trynke Hoekstsra, Katja van den Hurk
Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study. Journal of clinical medicine 11 (13) (2022)
Judita Rudokaite, Lee-Ling Sharon Ong, Mart P Janssen, Eric Postma, Elisabeth M J Huis In 't Veld
Predicting vasovagal reactions to a virtual blood donation using facial image analysis. Transfusion 62 (4) (2022)
Joost H J van Sambeeck, C Ellen Van Der Schoot, Nico M van Dijk, Henk Schonewille, Mart P Janssen
Extended red blood cell matching for all transfusion recipients is feasible. Transfusion medicine (Oxford, England) (2021)
Praiseldy Langi Sasongko, Katja van den Hurk, Marian van Kraaij, Etiënne A J A Rouwette, Vincent A W J Marchau, Mart P Janssen
Not a crystal ball: Mapping opportunities and threats for the future demand of red blood cells in the Netherlands using a scenario approach. Transfusion 61 (8) (2021)
Jessie S Luken, Claudia C Folman, Michaël V Lukens, Johan H Meekers, Peter C Ligthart, Henk Schonewille, Jaap Jan Zwaginga, Mart P Janssen, C Ellen Van Der Schoot, Johanna van der Bom, Masja De Haas
Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands. Transfusion 61 (3) (2021)
Rossana C Garzon Jimenez, Ryanne W Lieshout-Krikke, Mart P Janssen
West Nile virus and blood transfusion safety: A European perspective. Vox sanguinis 116 (10) (2021)
Ronald H G van de Weem, Merel L Wemelsfelder, Jessie S Luken, Masja De Haas, René W L M Niessen, C Ellen Van Der Schoot, Han Hoogeveen, Mart P Janssen
Preventing alloimmunization using a new model for matching extensively typed red blood cells. Vox sanguinis (2021)
Mart P Janssen, Claudius Micha Nübling, François-Xavier Lery, Yuyun S Maryuningsih, Jay S Epstein
A WHO tool for risk-based decision making on blood safety interventions. Transfusion 61 (2) (2020)
Marieke Vinkenoog, Katja van den Hurk, Marian van Kraaij, Matthijs van Leeuwen, Mart P Janssen
First results of a ferritin-based blood donor deferral policy in the Netherlands. Transfusion 60 (8) (2020)
Brian S Custer, Mart P Janssen, G Hubben, M Vermeulen, M van Hulst
Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV. Vox sanguinis 112 (6) (2017)
Mart P Janssen, A J W van Tilborgh, K M K de Vooght, A G Bokhorst, Johanna C Wiersum-Osselton
Direct costs of transfusion reactions - an expert judgement approach. Vox sanguinis 113 (2) (2017)
Mart P Janssen, M van Hulst, Brian S Custer, null null
An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries. Vox sanguinis 112 (6) (2017)